Refractory trichomoniasis in HIV-positive and HIV-negative subjects

Current Infectious Disease Reports

Volumn 13, Issue 6, 2011, Pages 595-603

  Miller, Megan R ^a   Nyirjesy, Paul ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

HIV; Metronidazole resistance; Paromomycin; Tinidazole; Trichomonas vaginalis; Vaginitis

Indexed keywords

ACETARSOL; ALLANTOIN PLUS AMINOACRIDINE PLUS SULFANILAMIDE; AMPICILLIN; COTRIMOXAZOLE; FURAZOLIDONE; GABBORAL; METRONIDAZOLE; NITROIMIDAZOLE DERIVATIVE; NONOXINOL 9; PAROMOMYCIN; POVIDONE IODINE; TINIDAZOLE; UNCLASSIFIED DRUG; ZINC SULFATE;

ANAPHYLACTIC SHOCK; ANGIONEUROTIC EDEMA; APPLICATION SITE EXCORIATION; APPLICATION SITE IRRITATION; APPLICATION SITE RASH; APPLICATION SITE URTICARIA; ARTICLE; BEDTIME DOSAGE; BLADDER IRRIGATION; CLINICAL FEATURE; CONFUSION; CROSS ALLERGY; CROSS RESISTANCE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DIZZINESS; DROWSINESS; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG DOSE REGIMEN; DRUG ELIMINATION; DRUG FEVER; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG MEGADOSE; EOSINOPHILIA; GASTROINTESTINAL SYMPTOM; HEART PALPITATION; HOT FLUSH; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMEDIATE TYPE HYPERSENSITIVITY; INFECTION; INSOMNIA; LEUKOPENIA; METALLIC TASTE; MORNING DOSAGE; NAUSEA; NONHUMAN; PARTNER INFECTION; PATIENT COMPLIANCE; PATIENT COUNSELING; PERIPHERAL NEUROPATHY; POINT OF CARE TESTING; PREGNANCY COMPLICATION; SENSITIVITY AND SPECIFICITY; SEXUAL COUNSELING; SEXUAL TRANSMISSION; SIDE EFFECT; SINGLE DRUG DOSE; TASTE; TISSUE DISTRIBUTION; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; VAGINA PAIN; VAGINA PESSARY; VAGINAL BURNING SENSATION; VAGINAL LAVAGE; VAGINAL ULCER; VOMITING; VULVOVAGINAL DISCOMFORT;

EID: 81155148316     PISSN: 15233847     EISSN: 15343146     Source Type: Journal    
DOI: 10.1007/s11908-011-0213-9     Document Type: Article

References (63)

1. DJ Helms DJ Mosure CA Metcalf, et al. 2008 Risk factors for prevalent and incident Trichomonas vaginalis among women attending three sexually transmitted disease clinics Sex Transm Dis 35 484 488 18360314 10.1097/OLQ.0b013e3181644b9c This article compares risk factors for prevalent and incident infections in a population of high-risk women (Pubitemid 351670550)
2. JS Huppert BE Batteiger P Braslins, et al. 2005 Use of an immunochromatographic assay for rapid detection of trichomonas vaginalis in vaginal specimens J Clin Microbiol 43 684 687 15695664 10.1128/JCM.43.2.684-687. 2005 1:CAS:528:DC%2BD2MXit1aqs74%3D (Pubitemid 40256019)
3. VJ Johnston DC Mabey 2008 Global epidemiology and control of Trichomonas vaginalis Curr Opin Infect Dis 21 56 64 18192787 10.1097/QCO.0b013e3282f3d999
4. B VanDerPol 2007 Trichomonas vaginalis infection: the most prevalent nonviral sexually transmitted infection receives the least public health attention Clin Infect Dis 44 23 25 10.1086/509934 (Pubitemid 44968979)
5. SL Cudmore KL Delgaty SF Hayward-McClelland, et al. 2004 Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis Clin Microbiol Rev 17 783 793 15489348 10.1128/CMR.17.4.783-793.2004 1:CAS:528:DC%2BD2cXhtVSht7jE (Pubitemid 39372517)
6. N Nanda RG Michel G Kurdgelashvili, et al. 2006 Trichomoniasis and its treatment Expert Rev Anti Infect Ther 4.1 125 10.1586/14787210.4.1.125
7. JN Krieger 1994 Trichomoniasis in men: old issues and new data Sex Trans Dis 22 83 96 10.1097/00007435-199503000-00003
8. AC Sena WC Miller MM Hobbs, et al. 2006 Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention Clin Infect Dis 44 13 22 17143809 10.1086/511144
9. RN Ficherova 2009 Impact of T. vaginalis infection on innate immune responses and reproductive outcome J Reprod Immunol 83 185 189 10.1016/j.jri.2009.08.007
10. MB Nye JR Schwebke BA Body 2009 Comparison of APTIMA Trichomonas vaginalis transcription-mediated amplification to wet mount microscopy, culture, and polymerase chain reaction for diagnosis of trichomoniasis in men and women Am J Obstet Gynecol 200 188e1 188e7 10.1016/j.ajog.2008.10.005 This study investigates the diagnostic accuracy of APTIMA Trichomonas NAAT test from multiple different specimens, compared to traditional methods (wet mount, culture and PCR), in both women and men. The data are well organized, and includes men, for whom little data exist in this regard
11. Sexually Transmitted Diseases Treatment Guidelines, 2010. Available at http://www.cdc.gov/std/treatment/2010/vaginal-discharge.htm#a2. Accessed May 2011.
12. L Campbell V Woods T Lloyd, et al. 2008 Evaluation of the OSOM trichomonas rapid test versus wet preparation examination for detection of Trichomonas vaginalis vaginitis in specimens from women with a low prevalence of infection J Clin Microbiol 46 3467 3469 18685008 10.1128/JCM.00671-08 1:CAS:528:DC%2BD1cXht12ru7zI The article investigates the diagnostic accuracy of the OSOM Trichomonas rapid test in a population with a low prevalence of infection, and evaluates the resources necessary to implement OSOM in a high-volume laboratory setting
13. Forna F, Gülmezoglu AM. Interventions for treating trichomoniasis in women. Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No.: CD000218. doi: 10.1002/14651858.CD000218.
14. TA Peterman LH Tian CA Metcalf, et al. 2006 High incidence of new sexually transmitted infections in the year following a sexually transmitted infection: a case for rescreening Ann Intern Med 145 564 572 17043338 (Pubitemid 46780935)
15. P Kissinger N Schmidt H Mohammed, et al. 2006 Patient-delivered partner treatment for Trichomonas vaginalis infection: a randomized controlled trial Sex Transm Dis 33 445 450 16531939 10.1097/01.olq.0000204511.84485.4c (Pubitemid 43964755)
16. MF Cotch JG Pastorek RP Nugent, et al. 1997 Trichomonas vaginalis associated with low birth weight and preterm delivery Sex Trans Dis 24 353 360 10.1097/00007435-199707000-00008 1:STN:280:DyaK2szoslOhtA%3D%3D (Pubitemid 27306585)
17. S Cauci JF Culhane 2007 Modulation of vaginal immune response among pregnant women with bacterial vaginosis by Trichomonas vaginalis, Chlamydia trachomatis, Neisseria gonorrhoeae, and yeast Am J Obstet Gynecol 196 133.e1 133.e7 10.1016/j.ajog.2006.08.033 (Pubitemid 46239977)
18. HN Simhan BL Anderson MA Krohn, et al. 2007 Host immune consequences of asymptomatic Trichomonas vaginalis infection in pregnancy Am J Obstet Gynecol 196 59.e1 59.e5 10.1016/j.ajog.2006.08.035 (Pubitemid 46107377)
19. JE Carter KC Whithaus 2008 Neonatal respiratory tract involvement by Trichomonas vaginalis: a case report and review of the literature Am J Trop Med Hyg 78 17 19 18187779 (Pubitemid 351844491)
20. Gülmezoglu AM. Interventions for trichomoniasis in pregnancy. Cochrane Database of Systematic Reviews 2010, Issue 1. Art. No.: CD000220. doi: 10.1002/14651858.CD000220.
21. MA Klebanoff JC Carey JC Hauth, et al. 2001 Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection N Engl J Med 345 487 493 11519502 10.1056/NEJMoa003329 1:CAS:528:DC%2BD3MXms1arsrk%3D (Pubitemid 32758500)
22. JA Upcroft LA Dunn JM Wright, et al. 2006 5-nitroimidazole drugs effective against metronidazole-resistant Trichomonas vaginalis and Giardia duodenalis Antimicrob Agents Chemother 50 344 347 16377707 10.1128/AAC.50.1.344- 347.2006 1:CAS:528:DC%2BD28XivVGqtQ%3D%3D (Pubitemid 43042942)
23. JR Schwebke FJ Barrientes 2006 Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole Antimicrob Agents Chemother 50 4209 4210 17000740 10.1128/AAC.00814-06 1:CAS:528: DC%2BD28XhtlWksrbO (Pubitemid 44865173)
24. JW Krashin EH Koumans AC Bradshaw-Sydnor, et al. 2009 Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population Sex Trans Dis 37 440 44 This interesting article explores the incidence, prevalence and risk factors for Trichomonas vaginalis infection in adolescents, a group of patients that is relatively unstudied in relation to T. vaginalis
25. LJ Waters SS Dave JR Deayton, et al. 2005 Recalcitrant Trichomonas vaginalis infection - a case series Int J STD AIDS 16 505 509 16004634 10.1258/0956462054308314 1:STN:280:DC%2BD2Mzlt12qsw%3D%3D (Pubitemid 41003156)
26. JG Lossick HL Kent 1991 Trichomoniasis: trends in diagnosis and management Am J Obstet Gynecol 165 1217 1951578 1:STN:280:DyaK38%2FlvFejtA%3D%3D
27. JG Lossick M Muller TE Gorrell 1986 In vitro drug susceptibility and doses of metronidazole required for cure in cases of refractory vaginal trichomoniasis J Infect Dis 153 948 55 3486237 10.1093/infdis/153.5.948 1:STN:280:DyaL287pvVSmtQ%3D%3D (Pubitemid 16114873)
28. Gillette H, Schmid GP, Moswe D, et al. Metronidazole-resistant Trichomonas vaginalis, a case series, 1985-1998 [abstract 067]. In: XIIIth meet- ing of the International Society of Sexually Transmitted Disease Research (Denver). July 11-14, 1999.
29. JD Sobel P Nyirjesy W Brown 2001 Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis Clin Infect Dis 33 1341 6 11565074 10.1086/323034 1:CAS:528:DC%2BD3MXotVWgtbc%3D (Pubitemid 32955184)
30. Nyirjesy P, Gilbert J, Mulcahy LJ. Resistant trichomoniasis: successful treatment with combination therapy. Sex Transm Dis. Accepted for Publication.
31. DJ Helms DJ Mosure WE Secor, et al. 2008 Management of Trichomonas vaginalis in women with suspected metronidazole hypersensitivity Am J Obstet Gynecol 198 370.e1 370.e7 10.1016/j.ajog.2007.10.795 This article explores the treatment options for T. vaginalis infection in women with metronidazole hypersensitivity, and includes the tolerability and efficacy of metronidazole desensitization and several other alternative treatments
32. MD Pearlman C Yashar S Ernst, et al. 1996 An incremental dosing protocol for women with severe vaginal trichomoniasis and adverse reactions to metronidazole Am J Obstet Gynecol 174 934 936 8633672 10.1016/S0002-9378(96) 70329-0 1:STN:280:DyaK283gtlGmtQ%3D%3D (Pubitemid 26111674)
33. ML Kurohara FK Kwong TB Lebherz 1991 Metronidazole hypersensitivity and oral desensitization J Allergy Clin Immunol 88 279 280 1880329 10.1016/0091-6749(91)90341-K 1:STN:280:DyaK3MzkvFCnsQ%3D%3D
34. RS McClelland L Sangare WM Hassan, et al. 2007 Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition J Infect Dis 195 698 702 17262712 10.1086/511278
35. M Magnus R Clark L Myers 2003 Trichomonas vaginalis among HIV-infected women: are immune status or protease inhibitor use associated with subsequent T. vaginalis positivity? Sex Transm Dis 30 839 843 14603092 10.1097/01.OLQ. 0000086609.95617.8D 1:CAS:528:DC%2BD3sXoslWlurk%3D (Pubitemid 37386215)
36. P Kissinger WE Secor RA Clark, et al. 2008 Early repeated infections with Trichomonas vaginalis among HIV-positive and HIV-negative women Clin Infect Dis 46 994 999 18444815 10.1086/529149 This article investigates the anomaly of recurrent T. vaginalis infection in HIV-positive individuals, and explores whether recurrent infections are due to reinfection or treatment failure (Pubitemid 351589863)
37. P Kissinger A Amedee RA Clark, et al. 2009 Trichomonas Vaginalis treatment reduces vaginal HIV-1 shedding Sex Transm Dis 36 11 16 19008776 10.1097/OLQ.0b013e318186decf This article furthers research on the association between T. vaginalis and HIV by establishing a connection between trichomoniasis and vaginal HIV shedding, and suggests the importance of T. vaginalis treatment in decreasing HIV spread
38. RO Gilbert G Elia DH Beach, et al. 2000 Cytopathogenic effect of Trichomonas vaginalis on human vaginal epithelial cells cultured in vitro Infect Immun 68 4200 4206 10858237 10.1128/IAI.68.7.4200-4206.2000 1:CAS:528:DC%2BD3cXktlyntLc%3D (Pubitemid 30434575)
39. PC Guenther WE Secor CS Dezzutti 2005 Trichomonas vaginalis-induced epithelial monolayer disruption and human immunodeficiency virus type 1 (HIV-1) replication: implications for the sexual transmission of HIV-1 Infect Immun 73 4155 4160 10.1128/IAI.73.7.4155-4160.2005 (Pubitemid 40923157)
40. J Rendon-Maldonado M Espinosa-Cantellano C Soler, et al. 2003 Trichomonas vaginalis: in vitro attachment and internalization of HIV-1 and HIV-1-infected lymphocytes J Eukaryot Microbiol 50 43 48 12674478 10.1111/j.1550-7408.2003. tb00104.x (Pubitemid 36333420)
41. F Sorvillo L Smith P Kerndt, et al. 2001 Trichomonas vaginalis, HIV, and African-Americans Emerg Infect Dis 7 927 932 11747718 10.3201/eid0706.010603 1:STN:280:DC%2BD3MnpvFWhtA%3D%3D (Pubitemid 33115770)
42. P Kissinger L Mena J Levison, et al. 2010 A randomized treatment trial: single versus 7-day dose of metronidazole for the treatment of Trichomonas vaginalis among HIV-infected women J Acquir Immune Defic Syndr 55 565 71 21423852 10.1097/QAI.0b013e3181eda955 1:CAS:528:DC%2BC3cXhsVWht7vF A randomized clinical trial comparing the efficacy of a single 2 g metronidazole dose with metronidazole 500 mg twice a day for seven days in HIV-positive women. Authors noted lower repeat T. vaginalis infection rates with the extended treatment
43. JS Huppert JE Mortensen JL Reed, et al. 2007 Rapid antigen testing compares favorably with transcription-mediated amplification assay for the detection of Trichomonas vaginalis in young women Clin Infect Dis 45 194 198 17578778 10.1086/518851 1:CAS:528:DC%2BD2sXoslGltrw%3D (Pubitemid 47041010)
44. AM Briselden SL Hillier 1994 Evaluation of affirm VP microbial identification test for Gardnerella vaginalis and Trichomonas vaginalis J Clin Microbiol 32 148 152 8126171 1:STN:280:DyaK2c7nt1Sisw%3D%3D
45. LR DeMeo DL Draper JA McGregor, et al. 1996 Evaluation of a deoxyribonucleic acid probe for the detection of Trichomonas vaginalis in vaginal secretions Am J Obstet Gynecol 174 1339 1342 8623867 10.1016/S0002-9378(96)70682-8 1:STN:280:DyaK287pvFyitg%3D%3D (Pubitemid 26131158)
46. DW Hager 2004 Treatment of metronidazole-resistant Trichomonas vaginalis with tinidazole: case reports of three patients Sex Transm Dis 31 343 345 15167642 10.1097/00007435-200406000-00004 (Pubitemid 38691962)
47. SC Tayal SA Ochogwu H Bunce 2010 Paromomycin treatment of recalcitrant Trichomonas vaginalis Int J STD AIDS 21 217 218 20215633 10.1258/ijsa.2009. 009085 1:STN:280:DC%2BC3c7ntV2nsg%3D%3D
48. P Nyirjesy 1995 Paromomycin for nitroimidazole-resistant trichomonosis Lancet 346 1110 7564825 10.1016/S0140-6736(95)91788-8 1:STN:280: DyaK28%2FisF2lsQ%3D%3D
49. DD Coelho 1997 Metronidazole resistant trichomoniasis successfully treated with paromomycin Genitourin Med 73 397 398 9534753 1:STN:280: DyaK1c7ps1amsA%3D%3D (Pubitemid 27479594)
50. WAJ Poppe 2001 Nitroimidazole-resistant vaginal trichomoniasis treated with paromomycin Eur J Obstet Gynecol 96 119 120 10.1016/S0301-2115(00)00403-6 1:STN:280:DC%2BD3M3it1Sktw%3D%3D (Pubitemid 32331862)
51. L DuBouchet MR Spence MF Rein, et al. 1997 Multicenter comparison of clotrimazole vaginal tablets, oral metronidazole, and vaginal suppositories containing sulfanilamide, aminacrine hydrochloride, and allantoin in the treatment of symptomatic trichomoniasis Sex Transm Dis 24 156 160 9132982 10.1097/00007435-199703000-00006 1:STN:280:DyaK2s3islGmtQ%3D%3D (Pubitemid 27123191)
52. PG Watson RS Pattman 1996 Arsenical pessaries in the successful elimination of metronidazole-resistant Trichomonas vaginalis Int J STD AIDS 7 296 297 8876365 10.1258/0956462961917852 1:STN:280:DyaK2s%2FjtVChtg%3D%3D (Pubitemid 26284150)
53. PP Walker RE Hall JD Wilson 1997 Arsenical pessaries in the treatment of metronidazole-resistant Trichomonas vaginalis Int J STD AIDS 8 473 9228600 10.1258/0956462971920424 1:STN:280:DyaK2sznt1elsg%3D%3D (Pubitemid 27270488)
54. MY Chen NA Smith EF Fox, et al. 1999 Acetarsol pessaries in the treatment of metronidazole resistant Trichomonas vaginalis Int J STD AIDS 10 277 280 12035784 10.1258/0956462991913943 1:STN:280:DC%2BD383psF2gug%3D%3D (Pubitemid 29168424)
55. S Bhaduri D Montford 2010 Paromomycin treatment of recalcitrant Trichomonas vaginalis Int J STD AIDS 21 529 20852211 10.1258/ijsa.2010.010208 1:STN:280:DC%2BC3cfjsVemtA%3D%3D
56. JJ Ratzan 1969 Monilial and Trichomonas Vaginitis: topical treatments with Povidine-Iodine preparations Calif Med 110 24 27 5762464 1:STN:280:DyaF1M%2FosV2iug%3D%3D
57. CH Livengood JG Lossick 1991 Resolution of resistant vaginal trichomoniasis associated with the use of intravaginal nonoxynol-9 Obstet Gynecol 78 954 956 1656351
58. NM Antonelli SJ Diehl JW Wright 2000 A randomized trial of intravaginal nonoxynol 9 versus oral metronidazole in the treatment of vaginal trichomoniasis Am J Obstet Gynecol 182 1008 1010 10819810 10.1067/mob.2000.105388 1:CAS:528:DC%2BD3cXktFCls7o%3D (Pubitemid 30353263)
59. ET Houang Z Ahmet AG Lawrence 1997 Successful treatment of four patients with recalcitrant vaginal trichomoniasis with a combination of zinc sulfate douche and metronidazole therapy Sex Transm Dis 24 116 119 9111758 10.1097/00007435-199702000-00010 1:STN:280:DyaK2s3msFyquw%3D%3D (Pubitemid 27074480)
60. LM Goldman JA Upcroft K Workowski, et al. 2009 Treatment of metronidazole-resistant Trichomonas vaginalis Sex Health 6 345 347 19917205 10.1071/SH09064
61. J Schwartz 1956 Tricofuron therapy of trichomonal vaginitis Obstet Gynecol 7 312 314 13297299 1:STN:280:DyaG28%2FkvFGrtw%3D%3D
62. A Mammen-Tobin JD Wilson 2005 Mangament of metronidazole-resistant Trichomonas vaginalis - a new approach Int J STD AIDS 16 488 490 16004628 10.1258/0956462054308422 1:STN:280:DC%2BD2Mzlt12rtw%3D%3D (Pubitemid 41003150)
63. S Wood CM Kennedy RP Galask 2007 Prolonged vaginal and oral metronidazole for refractory Trichomonas vaginalis J Reprod Med 52 1057 8 18161407 (Pubitemid 350305092)